News
Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced it will present new data from the REZILIENT2 trial of ...
Renowned Penn scientist Carl June and Jeff Marrazzo, founding CEO of Philly's Spark Therapeutics, are part of the leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback